Skip to main content
Rallis India Ltd logo

Rallis India Ltd — Investor Relations & Filings

Ticker · RALLIS ISIN · INE613A01020 LEI · 335800HI7I928BFJB442 BSE.NS Manufacturing
Open in API
Filings indexed 1,589 across all filing types
Latest filing 2023-07-15 Regulatory Filings
Country IN India
Listing BSE.NS RALLIS

About Rallis India Ltd

https://www.rallis.com/

Rallis India Ltd, a subsidiary of Tata Chemicals and a member of the Tata Group, specializes in providing comprehensive crop care solutions. The company's core business activities encompass the manufacturing and marketing of a diverse portfolio of agrochemicals, including insecticides, fungicides, and herbicides. Additionally, it maintains a significant presence in the seeds business, developing high-yielding hybrids for crops such as maize, paddy, and pearl millet. Rallis also offers plant growth nutrients and soil conditioners to enhance agricultural productivity. With a robust research and development framework and a vast distribution network, the company serves both domestic and international markets, exporting products to over 70 countries. Its operations are supported by integrated manufacturing facilities and a commitment to sustainable agricultural practices, positioning it as a key partner in the global agricultural value chain.

Recent filings

Filing Released Lang Actions
Pursuant to Regulations 30 and 33 of the SEBI LODR, we wish to inform you that the Board of Directors at the Meeting held today, inter alia, approved the Unaudited Financial Results of ....
Regulatory Filings
2023-07-15 English
Financial Result Updates
Regulatory Filings
2023-07-15 English
Pursuant to Regulation 30 of the SEBI Listing Regulations and further to our intimation on July 5, 2023, we would like to inform that the Analysts'' Call on the financial results for the ....
Regulatory Filings Classification · 95% confidence The document is a notification about the rescheduling of an analyst/institutional investor meeting to discuss the company's Q1 FY24 financial results. It mentions the date and time of the conference call and provides dial-in details for participants. There is no actual financial data or detailed financial report included in the text. The document serves as an announcement for an upcoming earnings call rather than the transcript or the earnings release itself. Therefore, it fits best under the category of Call Transcript (CT) if it were the transcript, but since this is only an announcement of the call, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about the scheduling of the call and does not contain the call transcript or financial results. The document length is short (2942 characters), and it is an announcement rather than a report or transcript.
2023-07-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about the rescheduling of an analyst/institutional investor meeting to discuss the company's Q1 FY24 financial results. It mentions the date and time of the conference call and provides dial-in details. There is no actual financial data or detailed report content included, only an announcement of the call. This fits the definition of a Call Transcript (CT) only if it contained the full transcript, but here it is just a meeting rescheduling notice and call details. It is not an earnings release (ER) because it does not contain financial highlights or results, only a meeting announcement. Given the content, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the scheduling of an investor call under SEBI Listing Regulations, without substantive financial data or transcript. The document length is short (2942 characters), supporting that it is an announcement rather than a full report or transcript.
2023-07-13 English
Board Meeting — RALLIS INDIA LIMITED has informed the Exchange about Board Meeting to be held on 15-Jul-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the…
Regulatory Filings
2023-07-05 English
Board Meeting — Financial Results
Capital/Financing Update Classification · 85% confidence The document is a notification dated July 5, 2023, informing about an upcoming Board Meeting scheduled for July 15, 2023, to consider and approve the unaudited financial results for the quarter ended June 30, 2023. It also announces an Analysts' Call on July 17, 2023, to discuss the Q1 FY24 financial performance. The document contains no actual financial data or detailed financial analysis but serves as an announcement of the meeting and the earnings call. The document length is 3187 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Capital/Financing Update (CAP) because it relates to financial results announcements and investor communication, or possibly as a Call Transcript (CT) if it contained the transcript, but since it only announces the call, it is not a transcript. However, the document is primarily an announcement of the Board Meeting and the earnings call, which aligns best with Capital/Financing Update (CAP).
2023-07-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.